Skip to content
Aussie8 – Lifestyle
Author:
Antharis Therapeutics
Lonza Issues Exclusive, Target-Specific License to Antharis Therapeutics to Advance Next-Generation Dual Payload ADCs for Gastrointestinal Cancers
June 16, 2026